Literature DB >> 25920404

Chronic obstructive pulmonary disease and sudden cardiac death: the Rotterdam study.

Lies Lahousse1, Maartje N Niemeijer2, Marten E van den Berg3, Peter R Rijnbeek3, Guy F Joos4, Albert Hofman2, Oscar H Franco2, Jaap W Deckers5, Mark Eijgelsheim6, Bruno H Stricker7, Guy G Brusselle8.   

Abstract

AIMS: Both sudden cardiac death (SCD) and chronic obstructive pulmonary disease (COPD) are common conditions in the elderly. Previous studies have identified an association between COPD and cardiovascular disease, and with SCD in specific patient groups. Our aim was to investigate whether there is an association between COPD and SCD in the general population. METHODS AND
RESULTS: The Rotterdam study is a population-based cohort study among 14 926 subjects aged 45 years and older with up to 24 years of follow-up. Analyses were performed with a (time dependent) Cox proportional hazard model adjusted for age, sex, and smoking. Of the 13 471 persons included in the analysis; 1615 had a diagnosis of COPD and there were 551 cases of SCD. Chronic obstructive pulmonary disease was associated with an increased risk of SCD (age- and sex-adjusted hazard ratio, HR, 1.34, 95% CI 1.06-1.70). The risk particularly increased in the period 2000 days (5.48 years) after the diagnosis of COPD (age- and sex-adjusted HR 2.12, 95% CI 1.60-2.82) and increased further to a more than three-fold higher risk in COPD subjects with frequent exacerbations during this period (age- and sex-adjusted HR 3.58, 95% CI 2.35-5.44). Analyses restricted to persons without prevalent myocardial infarction or heart failure yielded similar results.
CONCLUSION: Chronic obstructive pulmonary disease is associated with an increased risk for SCD. The risk especially increases in persons with frequent exacerbations 5 years after the diagnosis of COPD. This risk indicator could provide new directions for better-targeted actions to prevent SCD. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Cardiovascular mortality; Comorbidity; General population; Sudden cardiac death

Mesh:

Year:  2015        PMID: 25920404     DOI: 10.1093/eurheartj/ehv121

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  22 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

2.  Airways diseases: asthma, COPD and chronic cough highlights from the European Respiratory Society Annual Congress 2018.

Authors:  Imran Satia; Huda Badri; Lies Lahousse; Omar S Usmani; Antonio Spanevello
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

3.  The Rotterdam Study: 2018 update on objectives, design and main results.

Authors:  M Arfan Ikram; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2017-10-24       Impact factor: 8.082

4.  Mortality Outcomes of Patients with Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease.

Authors:  Sankar D Navaneethan; Jesse D Schold; Haiquan Huang; Georges Nakhoul; Stacey E Jolly; Susana Arrigain; Raed A Dweik; Joseph V Nally
Journal:  Am J Nephrol       Date:  2016-02-19       Impact factor: 3.754

5.  Pulmonary hospitalizations and ischemic heart disease events in patients with peripheral artery disease.

Authors:  Mary McGrae McDermott; Lu Tian; Richard G Wunderink; Ravi Kalhan; Melina R Kibbe; Philip Greenland; Russell Tracy; Lihui Zhao; Kiang Liu; Mark Huffman; John T Wilkins; Yihua Liao; Sanjiv Shah; Donald Lloyd Jones; David Green
Journal:  Vasc Med       Date:  2016-12-15       Impact factor: 3.239

6.  Chronic obstructive pulmonary disease as a risk factor for ventricular arrhythmias independent of left ventricular function.

Authors:  Tomas Konecny; Kiran R Somers; Jae Yoon Park; Alan John; Marek Orban; Rahul Doshi; Paul D Scanlon; Samuel J Asirvatham; Charanjit S Rihal; Peter A Brady
Journal:  Heart Rhythm       Date:  2017-10-03       Impact factor: 6.343

Review 7.  Radiation-induced heart disease in lung cancer radiotherapy: A dosimetric update.

Authors:  Xin Ming; Yuanming Feng; Chengwen Yang; Wei Wang; Ping Wang; Jun Deng
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

8.  Longitudinal change in lung function and subsequent risks of cardiovascular events: evidence from four prospective cohort studies.

Authors:  Yun-Jiu Cheng; Zhen-Guang Chen; Zhu-Yu Li; Wei-Yi Mei; Wen-Tao Bi; Dong-Ling Luo
Journal:  BMC Med       Date:  2021-07-02       Impact factor: 8.775

9.  The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD.

Authors:  Alberto Papi; Paul W Jones; Prashant S Dalvi; Kirsten McAulay; Tammy McIver; Sanjeeva Dissanayake
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-11-09

10.  Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study.

Authors:  Natalie Terzikhan; Katia M C Verhamme; Albert Hofman; Bruno H Stricker; Guy G Brusselle; Lies Lahousse
Journal:  Eur J Epidemiol       Date:  2016-03-05       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.